cancer vaccine

Cancer vaccine's 'narrow' fail won't stop IO heading to FDA

IO Biotech’s cancer vaccine has “narrowly” failed to beat Keytruda in a phase 3 melanoma trial, but the company remains hopeful of a path to approval.

James Waldron Aug 11, 2025 9:48am

Scancell picks winner from phase 2 cancer vaccine face-off

Jul 22, 2025 9:38am

layoffs job cuts fired exit restructuring layoff reduction

BioNTech's chief strategy officer heads for the exit

Jul 17, 2025 10:55am

medical data concept with hospital in the background

OSE shares 65% OS rate behind cancer vaccine's phase 2 win

Jun 3, 2025 7:05am

Apollomics tags out of TYG oncology pact to cut costs

Apr 4, 2025 6:45am

Otsuka gives cancer candidates the kiss-off on strategic grounds

Feb 14, 2025 5:30am